Terbinafine Market

Terbinafine is also known as Terbinafine hydrochloride (Lamisil).It is a synthetic allylamine antifungal.It is highly lipophilic in nature and tends to accumulate in skin, nails, and fatty tissues.Like other allylamines, terbinafine inhibits ergosterol synthesis by inhibiting the fungal squalene monooxygenase (also called squalene epoxidase), an enzyme that is part of the fungal cell wall synthesis pathway.

Terbinafine Market contains market size and forecasts of Terbinafine (Lamisil) in global, including the following market information:

Global Terbinafine (Lamisil) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Terbinafine (Lamisil) Market Sales, 2017-2022, 2023-2028, (KG)

Global top five Terbinafine (Lamisil) companies in 2021 (%)

The global Terbinafine (Lamisil) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Terbinafine (Lamisil) include Perrigo, Novartis Pharmaceuticals Corporation, Gokul Pharma, TEVA, Mylan Pharmaceuticals, Pfizer, Sivem Pharmaceuticals, Apotex Corporation and Auro Pharma Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Terbinafine (Lamisil) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Terbinafine (Lamisil) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Terbinafine (Lamisil) Market Segment Percentages, by Type, 2021 (%)

Oral

External Use

Global Terbinafine (Lamisil) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Terbinafine (Lamisil) Market Segment Percentages, by Application, 2021 (%)

Fungal Infection Of The Skin And Mucous Membrane

Onychomycosis

Bronchial Asthma

Gynecological Anti-Infection Preparation

Other

Global Terbinafine (Lamisil) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Terbinafine (Lamisil) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Terbinafine (Lamisil) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Terbinafine (Lamisil) revenues share in global market, 2021 (%)

Key companies Terbinafine (Lamisil) sales in global market, 2017-2022 (Estimated), (KG)

Key companies Terbinafine (Lamisil) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Perrigo

Novartis Pharmaceuticals Corporation

Gokul Pharma

TEVA

Mylan Pharmaceuticals

Pfizer

Sivem Pharmaceuticals

Apotex Corporation

Auro Pharma Inc

PLIVA

Jamp Pharma Corporation

Nu Pharm

Codal Synto

Qd Pharmaceuticals

Pharmel Inc

Smaart Pharmaceutticals

Qilu Pharmaceutical

Qingdao Jinfeng Pharmaceutical